Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis

References

• World Health Organization. WHO coronavirus (COVID-19) dashboard; 2022. Available from: https://covid19.who.int. Accessed February 2, 2022.
   Google Scholar
• Horwitz LI, Jones SA, Cerfolio RJ, et al. Trends in COVID-19 risk-adjusted mortality rates. J Hosp Med. 2021;16(2):90–92. doi:10.12788/jhm.3552
   PubMed Web of Science ®Google Scholar
• Xu S, Huang R, Sy LS, et al. COVID-19 vaccination and non–COVID-19 mortality risk — seven integrated health care organizations, United States, December 14, 2020–July 31, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(43):1520–1524. doi:10.15585/mmwr.mm7043e2
   PubMed Web of Science ®Google Scholar
• Elsawah HK, Elsokary MA, Abdallah MS, ElShafie AH. Efficacy and safety of remdesivir in hospitalized Covid-19 patients: systematic review and meta-analysis including network meta-analysis. Rev Med Virol. 2021;31(4):e2187. doi:10.1002/rmv.2187
   PubMed Web of Science ®Google Scholar
• Hospital utilization; 2022. Available from: https://protect-public.hhs.gov/pages/hospital-utilization. Accessed February 2, 2022.
   Google Scholar
• French G, Hulse M, Nguyen D, et al. Impact of hospital strain on excess deaths during the COVID-19 pandemic — United States, July 2020–July 2021. MMWR Morb Mortal Wkly Rep. 2021;70(46):1613–1616. doi:10.15585/mmwr.mm7046a5
   PubMed Web of Science ®Google Scholar
• Loffi M, Piccolo R, Regazzoni V, et al. Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection. Open Heart. 2020;7(2):e001428. doi:10.1136/openhrt-2020-001428
   PubMed Web of Science ®Google Scholar
• Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract. 2020;167:108382. doi:10.1016/j.diabres.2020.108382
   PubMed Web of Science ®Google Scholar
• Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9(8):909–923. doi:10.1016/S2213-2600(21)00095-3
   PubMed Web of Science ®Google Scholar
• Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26(1):30–39. doi:10.1038/s41380-020-00880-7
   PubMed Web of Science ®Google Scholar
• Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A. The effect of smoking on COVID‐19 severity: a systematic review and meta‐analysis. J Med Virol. 2020. doi:10.1002/jmv.26389
   Web of Science ®Google Scholar
• Leung JM, Yang CX, Tam A, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020;55(5):2000688. doi:10.1183/13993003.00688-2020
   PubMed Web of Science ®Google Scholar
• Acevedo N, Escamilla-Gil JM, Espinoza H, et al. Chronic obstructive pulmonary disease patients have increased levels of plasma inflammatory mediators reported upregulated in severe COVID-19. Front Immunol. 2021;12:678661. doi:10.3389/fimmu.2021.678661
   PubMed Web of Science ®Google Scholar
• Singh D, Mathioudakis AG, Higham A. Chronic obstructive pulmonary disease and COVID-19: interrelationships. Curr Opin Pulm Med. 2022;28(2):76–83. doi:10.1097/MCP.0000000000000834
   PubMed Web of Science ®Google Scholar
• Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J. 2020;56(2):2002108. doi:10.1183/13993003.02108-2020
   PubMed Web of Science ®Google Scholar
• Pardhan S, Wood S, Vaughan M, Trott M. The risk of COVID-19 related hospitalsation, intensive care unit admission and mortality in people with underlying asthma or COPD: a systematic review and meta-analysis. Front Med. 2021;8:668808. doi:10.3389/fmed.2021.668808
   Web of Science ®Google Scholar
• Gerayeli FV, Milne S, Cheung C, et al. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;33:100789. doi:10.1016/j.eclinm.2021.100789
   PubMedGoogle Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of covid-19 — final report. N Engl J Med. 2020;383(19):1813–1826. doi:10.1056/NEJMoa2007764
   PubMed Web of Science ®Google Scholar
• Chow JH, Khanna AK, Kethireddy S, et al. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg. 2021;132(4):930–941. doi:10.1213/ANE.0000000000005292
   PubMed Web of Science ®Google Scholar
• Clemente-Moragón A, Martínez-Milla J, Oliver E, et al. Metoprolol in critically ill patients with COVID-19. J Am Coll Cardiol. 2021;78(10):1001–1011. doi:10.1016/j.jacc.2021.07.003
   PubMed Web of Science ®Google Scholar
• Pakhchanian H, Raiker R, Mukherjee A, Khan A, Singh S, Chatterjee A. Outcomes of COVID-19 in CKD patients: a multicenter electronic medical record cohort study. CJASN. 2021;16(5):785–786. doi:10.2215/CJN.13820820
   PubMed Web of Science ®Google Scholar
• Higham A, Mathioudakis A, Vestbo J, Singh D. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev. 2020;29(158):200199. doi:10.1183/16000617.0199-2020
   PubMed Web of Science ®Google Scholar
• Jie GW, Hua LW, Shi Y, et al. Chronic respiratory diseases and the outcomes of COVID-19: a nationwide retrospective cohort study of 39,420 Cases. J Allergy Clin Immunol Pract. 2021;9(7):2645–2655.e14. doi:10.1016/j.jaip.2021.02.041
   PubMed Web of Science ®Google Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.0233147
   PubMed Web of Science ®Google Scholar
• Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging. 2020;12(13):12493–12503. doi:10.18632/aging.103579
   PubMedGoogle Scholar
• Jeong JS, Kim JS, You YS, Yeom SW, Lee YC. COPD is a risk factor for COVID-19, but does not confer increased severity of the disease. Respir Med. 2021;189:106640. doi:10.1016/j.rmed.2021.106640
   PubMed Web of Science ®Google Scholar
• Chaplin S. COVID‐19: a brief history and treatments in development. Prescriber. 2020;31(5):23–28. doi:10.1002/psb.1843
   Google Scholar
• Sieńko J, Kotowski M, Bogacz A, et al. COVID-19: the influence of ACE genotype and ACE-I and ARBs on the course of SARS-CoV-2 infection in elderly patients. Clin Interv Aging. 2020;15:1231–1240. doi:10.2147/CIA.S261516
   PubMed Web of Science ®Google Scholar
• Möhlendick B, Schönfelder K, Breuckmann K, et al. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19. Pharmacogenet Genomics. 2021;31(8):165–171. doi:10.1097/FPC.0000000000000436
   PubMed Web of Science ®Google Scholar
• Gintoni I, Adamopoulou M, Yapijakis C. The impact of ACE and ACE2 gene polymorphisms in pulmonary diseases including COVID-19. In Vivo. 2022;36(1):13–29. doi:10.21873/invivo.12672
   PubMed Web of Science ®Google Scholar
• Fließer E, Birnhuber A, Marsh LM, et al. Dysbalance of ACE2 levels – a possible cause for severe COVID‐19 outcome in COPD. J Pathol Clin Res. 2021;7(5):446–458. doi:10.1002/cjp2.224
   PubMedGoogle Scholar
• Keller TL, Wright J, Donovan LM, et al. Association of patient and primary care provider factors with outpatient COPD care quality. Chronic Obstr Pulm Dis. 2022;9(1):55–67. doi:10.15326/jcopdf.2021.0232
   PubMed Web of Science ®Google Scholar
• Yamaya M, Nishimura H, Deng X, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58(3):155–168. doi:10.1016/j.resinv.2019.12.005
   PubMed Web of Science ®Google Scholar
• Gothe H, Rajsic S, Vukicevic D, et al. Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review. BMC Health Serv Res. 2019;19:737. doi:10.1186/s12913-019-4574-3
   PubMed Web of Science ®Google Scholar
• Aleem A, Akbar Samad AB, Slenker AK Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19). StatPearls: StatPearls Publishing; 2021. Available from: http://www.ncbi.nlm.nih.gov/books/NBK570580/. Accessed January 6, 2022.
   Google Scholar
• O’Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005;40(5 Pt 2):1620–1639. doi:10.1111/j.1475-6773.2005.00444.x
   PubMed Web of Science ®Google Scholar